健康科学ジャーナル

  • ISSN: 1108-7366
  • ジャーナル h-index: 51
  • 雑誌引用スコア: 10.69
  • ジャーナルのインパクトファクター: 9.13
インデックス付き
  • Genamics JournalSeek
  • 中国国家知識基盤 (CNKI)
  • サイテファクター
  • シナール完了
  • シマゴ
  • 電子ジャーナルライブラリ
  • 研究ジャーナル索引作成ディレクトリ (DRJI)
  • EMケア
  • OCLC-WorldCat
  • 大学補助金委員会
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • Google スカラー
  • シェルパ・ロメオ
  • 秘密検索エンジン研究所
このページをシェアする

抽象的な

Human Papillomavirus and Cancer in Men

Chandrika Johnson, Nosa Obanor, Amanda DeWeese

Although human papillomavirus (HPV) issues have focused primarily on females, it is important to give attention to males because the primary mode of transmission of the virus is through sexual intercourse. There is increasing evidence that HPV is causing serious diseases like penile, anal, head, and neck cancer among males. Studies have also shown that, generally, males have similar rates of HPV infection (0.29 to 0.39 per 1000 person-month) as females. The vaccine against HPV, Gardasil®, has been used in women since 2006. In 2009, the FDA approved Gardasil® for men. Although questions about the efficacy of HPV vaccination in males remain, it is important to understand what males know about HPV and their predisposition towards being vaccinated against the virus.